First Midwest Bank Trust Division’s Aurinia Pharmaceuticals AUPH Stock Holding History

First Midwest Bank Trust Division’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$651K	Buy	+28,459	New	+$674K	0.08%	224

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

MAM

Melqart Asset Management London, United Kingdom $1.05B AUM 111.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

First Midwest Bank Trust Division's AUPH Position: Q4 2021 in Review

First Midwest Bank Trust Division opened a new position in Aurinia Pharmaceuticals (AUPH) in Q4 2021: 28,459 shares worth $651K. The stake represents 0.08% of the portfolio and ranks #224 among its holdings.

191 funds tracked by Wall St. Rank hold AUPH as of Q4 2021.

First Midwest Bank Trust Division held 28,459 shares of Aurinia Pharmaceuticals worth $651K as of Q4 2021.
Aurinia Pharmaceuticals was a new First Midwest Bank Trust Division position in Q4 2021.
Aurinia Pharmaceuticals made up 0.08% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #224 holding.
191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.